When someone has a severe heart attack, their body sounds an alarm deep inside the bones. The bone marrow, our blood-cell factory, starts releasing half-formed soldiers called immature neutrophils—white blood cells that aren't fully ready for battle yet. Now, researchers at the University of Münster in Germany have found that these unfinished cells floating in the bloodstream can tell doctors how likely a patient is to survive the next month.
Professor Oliver Soehnlein and his team at the Institute of Experimental Pathology wanted to understand why some heart attack patients recover while others don't. They studied blood samples from more than 200 patients who had experienced heart attacks, strokes, or heart failure, comparing them to healthy people. Using a high-resolution technique called spectral flow cytometry, which can examine individual cells in incredible detail, they tracked how neutrophil maturation changed during these emergencies.
The pattern was striking. The sicker the patient, the more immature their white blood cells appeared. In patients with the most severe type of heart attack—called ST-elevation myocardial infarction, where a coronary artery becomes completely blocked—researchers even found very early precursor cells called preneutrophils. "We were surprised at how clearly the severity of the disease is reflected in the maturity of the released cells," said Mathis Richter, a PhD student who was the study's first author.
The discovery matters because it gives doctors a new way to spot high-risk patients immediately upon arrival at the hospital. These immature cells show up in a standard test called a differential blood count, which most hospitals already perform. The test measures "immature granulocytes" (IG)—cells that haven't fully matured. When the IG count was high, patients faced a much greater risk of dying within 30 days. In fact, the IG value turned out to be a better predictor of early death than markers doctors have relied on for years.
This remained true even after accounting for other known risk factors like age, diabetes, or smoking history. The immature cell count seemed to provide information that went beyond what doctors already knew about their patients.
The findings, published in the journal Nature Cardiovascular Research, could eventually help hospitals triage heart attack patients more effectively—spending extra attention on those whose blood shows the signature of a bone marrow in emergency mode. Since the test requires no special equipment, it could be especially useful in smaller hospitals that lack advanced cardiac care centers.
Neutrophil mobilization during heart attacks has been observed for nearly a century, but this study finally points to its practical value: a simple lab value that speaks volumes about survival odds.